Joshua Funder PhD

Non-executive Director

Dr Funder has been with GBS Venture Partners since 2004 and has significant experience in biotechnology management, business strategy and the international pharmaceutical industry. Before joining GBS he worked in corporate strategy and development at Infinity Pharmaceuticals, a drug discovery start-up in Boston. Dr Funder has also worked as a consultant at the Boston Consulting Group in San Francisco, focusing primarily on corporate strategy in the high-tech and bio-pharmaceutical sectors. In addition, he worked with the Clinton Foundation HIV/AIDS Initiative to successfully negotiate reduced prices for anti-retrovirals and initiate pharmaceutical supplies across eastern and southern Africa. Dr Funder has served as interim CEO of Proacta, Inc. and is on the board of directors of GBS portfolio companies OPAL Inc. and Pacific Therapeutics.

Dr Funder has a Bachelor of Science (Honours) and Bachelor of Laws (Honours) degrees from Melbourne University and a Master of Laws degree from the London School of Economics. He also holds a D.Phil in intellectual property for biotechnology from Oxford University where he studied as a Rhodes Scholar.